Tolerability and Efficacy of a Medical Device Repairing Emollient Cream in Children and Adults with Mild to Moderate Atopic Dermatitis.

Authors:
Andreas Pinter
Andreas Pinter
University of Frankfurt
Ana Beatris Rossi
Ana Beatris Rossi
Virginia Clinical Research
United States

Dermatol Ther (Heidelb) 2019 Jun 9;9(2):309-319. Epub 2019 Apr 9.

Clinical Skin Research and Development Center, Hôtel Dieu, Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Introduction: Regular emollient application is recommended for managing atopic dermatitis (AD). Although many emollients are available, only AD-tested medical device repairing emollient creams (MDRECs) can be recommended for treating and preventing AD skin lesions. Here, we evaluated the tolerability and benefit of a new MDREC in an open-label study in infants, young children, and adults with mild to moderate AD.

Methods: Subjects (or their parents or guardians) were instructed to apply the MDREC to AD lesions or areas of dry skin twice daily for 3 weeks. Investigators assessed tolerability and AD severity at days 1, 8, and 22. Subjects assessed AD severity weekly, recorded any adverse events, and reported their satisfaction with the MDREC at day 22.

Results: Sixty-one subjects (19 infants, 22 children, and 20 adults) were included and 59 completed the study. At inclusion, 49% of the infants and young children and 15% of the adults were experiencing flares of AD. At day 22, the local tolerability of the MDREC was judged by the investigators as excellent in all the children and in 18 of the 20 adult subjects (90%). All adverse events were mild and transient. Investigator- and subject-assessed AD severity progressively decreased at each assessment for each age subgroup.

Conclusion: This study shows that the MDREC was well tolerated when applied to AD skin lesions in infants, young children, and adults and suggests this product can be used daily to control the signs and symptoms of AD.

Funding: Laboratoires Dermatologiques Ducray, Pierre Fabre Dermo-Cosmétique.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-019-0295-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522571PMC
June 2019

Publication Analysis

Top Keywords

children adults
16
infants young
12
young children
12
skin lesions
8
adults mild
8
mild moderate
8
adverse events
8
repairing emollient
8
atopic dermatitis
8
device repairing
8
medical device
8
children
6
adults
5
mdrec
5
completed study
4
study inclusion
4
included completed
4
infants children
4
subjects infants
4
inclusion 49%
4

References

(Supplied by CrossRef)
Article in Ann Nutr Metab
S Nutten et al.
Ann Nutr Metab 2015
Article in Lancet
DY Leung et al.
Lancet 2003
Article in Lancet
MI Asher et al.
Lancet 2006
Article in Am J Clin Dermatol
C Blome et al.
Am J Clin Dermatol 2016
Article in Dermatol Res Pract
M Catherine Mack Correa et al.
Dermatol Res Pract 2012
Article in J Am Acad Dermatol
LF Eichenfield et al.
J Am Acad Dermatol 2014
Article in Br J Dermatol
M Loden et al.
Br J Dermatol 1999
Article in J Allergy Clin Immunol
PM Elias et al.
J Allergy Clin Immunol 2008
Article in Acta Derm Venereol
M Loden et al.
Acta Derm Venereol 2010
Article in Cochrane Database Syst Rev
EJ Zuuren van et al.
Cochrane Database Syst Rev 2017
Article in Dermatol Ther (Heidelb)
AB Rossi et al.
Dermatol Ther (Heidelb) 2018

Similar Publications